Only about 10% of drugs that start clinical trials get approved by the FDA. This rigorous process ensures that only the most effective and safest treatments reach patients, and clinical trials are essential for developing new therapies and improving patient outcomes. Clinical trials also help identify potential side effects, optimal dosages, and long-term benefits. However, with slower turnaround times, developing a new drug takes longer. Looking for premium clinical trial support? Check out how Actu-Real can help - https://lnkd.in/dvePtiSE Follow Actu-Real for more insightful posts on #healthcare, AI, machine learning, health economics, outcomes research, and real-world data. #ClinicalTrials #MedicalResearch #Innovation #PatientCare
Actu-Real, Inc.
Business Consulting and Services
Alpharetta, Georgia 2,076 followers
We help biopharma, healthcare and insurance companies make the right data-driven decisions.
About us
Actu-Real’s mission is to combine statistical, actuarial, data sciences, drug development and health economics expertise to enable data-driven, evidence-based design and implementation of risk-sharing framework and decisions in healthcare and insurance. Our differentiation is our cross-functional expertise, along with rich pharmaceutical and insurance industry experience, and leadership experience across strategy and operations, in a global and cross-cultural model. Our solutions and services for biopharma and healthcare industries help payers, providers and pharmaceutical companies optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization. Our offerings for the insurance industry include consultancy and services to maintain and manage client data, apply apt statistical methodology to derive insights from data to help optimize product design and operations.
- Website
-
http://www.actu-real.com
External link for Actu-Real, Inc.
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- Alpharetta, Georgia
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Statistics, Data Science, Biopharmaceutical product development, Healthcare, Health Economics and Outcomes Research, Market Access and Pricing, and Valuation and Employee Benefits
Locations
-
Primary
221 Roswell St
Alpharetta, Georgia 30009, US
-
163 Mahatma Society
Kothrud
Pune, Maharashtra 411038, IN
Employees at Actu-Real, Inc.
Updates
-
Today's quickly evolving healthcare landscape needs swift market access for ever-coming new treatments. Innovative approaches are paving the way for this. Conditional Approvals, based on early trial data and Managed Entry Agreements that ensure controlled market entry, are two innovative ways to enable rapid market access. Through such innovative and collaborative approaches, we can overcome traditional market access challenges and ensure that patients get the latest treatments in shorter times. Explore Actu-Real’s innovative service offerings that let you bridge the gaps in your market access strategy. https://lnkd.in/dbGurcNM #ActuReal #MarketAccess #Healthcare #HealthcareAccess
-
-
Recently, the FDA has accepted a supplemental New Drug Application (sNDA) for brexpiprazole in combination with sertraline to treat adults with post-traumatic stress disorder (PTSD). This combination therapy, supported by data from three randomized clinical trials, demonstrated consistent reductions in #PTSD symptoms. If approved, it would be the first FDA-approved pharmacological option for PTSD in over 20 years. PTSD is a prevalent mental health disorder, affecting approximately 13 million adults annually in the US. Read the complete article here: https://lnkd.in/gqDN3yKa Follow Actu-Real for more insightful posts on #healthcare, AI, machine learning, health economics, outcomes research, and real-world data. #ActuReal #Trending #Healthcare #FDA #PTSDTreatment
-
-
A 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐲 is an information system created for the collection, storage, and management of data on individuals with cancer. These registries are essential for cancer surveillance, providing insights into the progress of efforts to reduce the cancer burden. This surveillance data also serves as a foundation for #cancerresearch and is used to plan and evaluate cancer prevention and control initiatives. These data are reported to a central statewide registry from various medical facilities. Data collected by state cancer registries enable public health professionals to better understand and address the cancer burden. Follow Actu-Real for more insightful posts on #healthcare, AI, machine learning, health economics, outcomes research, and real-world data. #ActuReal #WordoftheDay #Cancer
-
-
#HealthEconomics and Outcomes Research (HEOR) data plays a more prominent role in healthcare decision-making. By harnessing HEOR data, healthcare decision-makers can efficiently allocate resources and prioritize high-value treatments by providing comprehensive insights into the cost-effectiveness, outcomes, and real-world impact of different medical interventions. By analyzing this data, stakeholders can identify which treatments offer the best value for patients. It can balance efficacy and cost, thus ensuring that limited healthcare resources are used most effectively. This evidence-based approach supports the development of strategies that optimize patient outcomes while controlling expenses, ultimately leading to a more sustainable and equitable healthcare system. Learn more about Actu-Real’s pragmatic Healthcare Economics and Outcomes Research offerings here: https://lnkd.in/dHN5gX4Y #ActuReal #Healthcare #HEOR #DataDrivenInsights
-
-
A global study by McMaster University confirmed that antacid pantoprazole helps prevent upper gastrointestinal bleeding in critically ill patients on ventilators. The REVISE trial, involving over 4,800 patients across eight countries, showed a significant reduction in bleeding with pantoprazole compared to placebo, though it did not reduce mortality rates. An updated meta-analysis of 12 trials involving 10,000 patients reinforced these findings, showing reduced bleeding risk without significant effects on mortality, pneumonia, or C. difficile infection. The findings will aid in improving care for critically ill ventilated patients Read the complete story here: https://lnkd.in/gibVH38T Looking for premium clinical trial support? Check out how Actu-Real can help - https://lnkd.in/dvePtiSE #Research #ClinicalTrials #RandomizedControlTrials
-
-
Artificial Intelligence (AI) is playing an increasingly important role in accelerating medical discovery. #AI can analyze vast datasets from clinical trials to identify patterns, predict potential treatment responses, and optimize trial design. This allows for faster recruitment of suitable participants, more efficient data analysis, and a quicker path to bringing life-saving treatments to patients. Looking for premium clinical trial support? Check out how Actu-Real can help - https://lnkd.in/dvePtiSE Follow Actu-Real for more insightful posts on #healthcare, AI, machine learning, health economics, outcomes research, and real-world data. #ActuReal #ClinicalTrials #Healthcare #AI
-
-
Actu-Real wishes you a happy and healthy 4th of July! May this day be filled with joy, freedom, and good health for you and your loved ones. #ActuReal #Healthcare #IndependenceDay #4thofJuly
-
Digital innovation is revolutionizing healthcare access. Telehealth platforms enable remote consultation with healthcare providers, particularly in underserved areas. This eliminates geographical barriers and allows patients living in remote locations to receive timely and convenient care. Technologies such as wearable and mobile apps facilitate continuous health monitoring and provide valuable data that can be shared with healthcare professionals to tailor personalized treatment plans. Electronic Health Records (EHRs) have transformed the healthcare landscape by streamlining the storage and sharing of patient information, enhancing care coordination among different providers, reducing the risk of medical errors, and ensuring up-to-date accessibility of patients' medical histories. Explore Actu-Real’s innovative service offerings that let you bridge the gaps in your market access strategy. https://lnkd.in/dbGurcNM #ActuReal #MarketAccess #HealthcareAccess #AI
-
-
ISPOR, a leading organization for Health Economics and Outcomes Research (#HEOR), has published a Good Practices Report that introduces a framework for assessing Electronic Health Records (#EHR) data for Health Technology Assessments (#HTA). The report is titled “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist.” The SUITABILITY Checklist Focuses on Data Characteristics, Provenance, Governance, and Fitness-For-Purpose to Assess Data Quality. It can offer robust EHR-derived data to improve health technology assessments (HTA) by providing unique depth and detail on patients' health and care. This can lead to more accurate assessments of the effectiveness of new treatments. Read the complete report here: https://lnkd.in/gEeVCGPF Follow Actu-Real for more insightful posts on #healthcare, AI, machine learning, health economics, outcomes research, and real-world data. #ActuReal #Healthcare #Research #TrendingNews
-